Friberg Gregory R 5
5 · BIOMARIN PHARMACEUTICAL INC · Filed Feb 13, 2026
Insider Transaction Report
Form 5
Friberg Gregory R
EVP, Chief R&D Officer
Transactions
- Award
Common Stock
[F1]2025-10-31$45.53/sh+398$18,123→ 43,904 total
Footnotes (1)
- [F1]Represents the shares acquired by the reporting person on October 31, 2025, pursuant to the issuer's Employee Stock Purchase Plan.
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact|2026-02-13